About
Board of Directors
PJ Anand
Founder, President and Chief Executive Officer
Alcyone Therapeutics, Inc.
Alcyone Therapeutics, Inc.
Norbert G. Riedel, PhD
Chairman of the BoardChairperson, Eton Pharmaceuticals, Inc., Director, Jazz Pharmaceuticals
and Director, Cerevel Therapeutics Holdings, Inc.
and Director, Cerevel Therapeutics Holdings, Inc.
Stephen Oesterle, MD
Health Care Industry Consultant
Former Senior Vice President, Medicine & Technology, Medtronic
Former Senior Vice President, Medicine & Technology, Medtronic
Edgar D. Jannotta, Jr
Former Managing Principle and Co-Manager of Healthcare Group
GTCR Golder Rauner, LLC
GTCR Golder Rauner, LLC
David Donabedian, PhD, MBA
Co-founder and Chief Executive Officer of DEM Therapeutics
and Venture Partner at Longwood Venture Fund
and Venture Partner at Longwood Venture Fund
Richard Upton
Partner, Harbor Light Capital Partners
Cameron Durrant, MD, DRCOG, DIPCH, MRCGP, MBA
Founder, Taran Therapeutics
Dennis Durbin, MD, MSCE
Board Observer
President and Chief Scientific Officer, Abigail Wexler Research Institute,
Nationwide Children’s Hospital Professor of Pediatrics, Ohio State University
President and Chief Scientific Officer, Abigail Wexler Research Institute,
Nationwide Children’s Hospital Professor of Pediatrics, Ohio State University
Kathrin Meyer, PhD
Board Observer
Chief Scientific Officer and Chair of the Scientific Advisory Board, Alcyone Therapeutics, Inc.
Chief Scientific Officer and Chair of the Scientific Advisory Board, Alcyone Therapeutics, Inc.
Lisa Shafer
Board Observer
Vice President, Product Development and Reg CMC, Medical Devices and Packaging, Biogen.
Vice President, Product Development and Reg CMC, Medical Devices and Packaging, Biogen.